Filing Flows

Filing Flows › Companies › Cardinal Health › Report card

Cardinal Health earnings report card

Every report on file against what analysts and the company itself expected, and what the stock did

Beat rate5 of 5 reports beat the EPS estimate

Cardinal Health (CAH) beat the analysts' EPS estimate in 5 of its last 5 reports (100%), by +12.2% on average. On report days the stock moved 3.7% in either direction on median (largest 16.0%), rising 60% of the time; after a beat it rose 60% of the time.

Beat rate100% of 5
Average surprise+12.2%
Median move on the day±3.7%
Rose on the day60%

Report by report

QuarterReportedEPS est.EPS reportedSurpriseRevenue reportedStock, the dayvs market
Q1 FY27Nov 5, 2026$2.94$3.26+10.9%$67.5B+3.7%+7.9%
Q to Jun 2026Aug 11, 2026$2.42$2.60+7.4%—-1.3%-1.2%
Q3 FY26Apr 30, 2026$2.79$3.17+13.7%$60.9B-3.7%-5.0%
Q2 FY26Feb 5, 2026$2.37$2.63+11.2%$65.6B+9.4%+8.8%
Q1 FY26Oct 30, 2025$2.17$2.55+17.6%$64.0B+16.0%+16.8%

Estimates and reported EPS are the Street's adjusted figures. Revenue reported is from the company's filing. The stock's move is close to close around the report date (the close before it to the close of the session after), against SPY for the market column.

Charts

Cardinal Health: EPS reported against the estimateCardinal Health: EPS reported against the estimateEstimateReported$2.17$2.55Q1 FY26$2.37$2.63Q2 FY26$2.79$3.17Q3 FY26$2.42$2.60Q to Jun 20…$2.94$3.26Q1 FY27
Latest (Q1 FY27): Estimate $2.94, Reported $3.26.
CAH: the stock's move on each report dayCAH: the stock's move on each report dayQ1 FY27+3.7%Q to Jun 2026-1.3%Q3 FY26-3.7%Q2 FY26+9.4%Q1 FY26+16.0%
Close to close around the report, from the daily price history.

The earnings-day move

Over 5 reports the stock moved 3.7% on median on the day (close to close), the largest move 16.0%.

After a beat the stock rose 60% of the time (5 beats).

The next report: what to expect → Cardinal Health: every quarter →

Read automatically from SEC filings, earnings releases and public estimates; errors are possible. Not investment advice.